SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ) fair value: what the stock is really worth
As of Sep 21, 2026: fair value of SINGAPORE PAINCARE HOLDINGS LIMITED S$0.33, price S$0.07, upside +415.0%, quality 59 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch SINGAPORE PAINCARE HOLDINGS LIMITED for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 29, 2026.
How to read this chart
60‑month range 0.0600 SGD – 0.2309 SGD · fair‑value band 0.1983 SGD – 0.4063 SGD · the 0.0650 SGD price screens below the 0.3348 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 29, 2026.
Follow SINGAPORE PAINCARE HOLDINGS in your weekly email
Every Wednesday you see whether SINGAPORE PAINCARE HOLDINGS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It operates general practitioner clinics, specialist clinics, traditional Chinese medicine centers, and physiotherapy centers for pain screening and treatments, cancer pain therapy, pharmacotherapy, and cognitive behavioral therapy.
Show more
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It operates general practitioner clinics, specialist clinics, traditional Chinese medicine centers, and physiotherapy centers for pain screening and treatments, cancer pain therapy, pharmacotherapy, and cognitive behavioral therapy. The company was founded in 2007 and is based in Singapore.
Stock analysis
SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ) currently trades at 0.0650 SGD, while our model-based Fair Value estimate is 0.3348 SGD, implying the stock looks roughly 80.6% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 0.5200 SGD per share, and 13 of the 13 models we run sit above the 0.0650 SGD price.
Bear case: the Asset-Based group reads lowest at 0.0700 SGD, and 0 of the 13 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.1983 SGD (bear) to 0.4063 SGD (bull), the price of 0.0650 SGD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 59/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
SINGAPORE PAINCARE HOLDINGS LIMITED reported revenue of 26.9M SGD in FY2024 versus 9.6M SGD in FY2020, a compound +29.2%/yr. Reported net income was −4.0M SGD in FY2025.
Key figures
Market cap 11.1M SGD (≈ $8.7M) · P/S ratio 0.39 · EPS (TTM) −0.0300 SGD · Dividend yield 5.8% · Net margin −18.4% · Return on equity −21.8% · Return on assets (EBIT) 16.0% · Operating margin 1.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 59% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 415%, FRQ screens cheaper than that median.
Fair Value models
Bear 0.1983 SGDFair Value 0.3348 SGDBull 0.4063 SGD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.54/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+21.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+34.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+47.2%
’19
’20
’21
’22
’23
’24
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+9.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+3.5%
Dividend (yield on the price)5.8%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−9.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Singapore: IMF forecast 2.0% a year to 2030, 1.7% from 2016 to 2025) that is about −11.4% a year for the price.
Compare SINGAPORE PAINCARE HOLDINGS LIMITED with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 246 stocks
Beats the industry median on 7/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score59 · Above median
Fair Value upside+200.0% · Top 25%
Profitability
Return on assets−0.6% · Bottom 25%
Net margin (TTM)−18.4% · Bottom 25%
Operating margin (TTM)1.8% · Bottom 25%
Growth and dividend
Revenue growth−2.9% · Bottom 25%
Dividend yield (TTM)5.8% · Top 25%
Balance sheet
Debt / equity0.03× · Lowest 25%
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ) overvalued or undervalued?
As of Sep 29, 2026, our model estimates a fair value of 0.3348 SGD versus the last price from Sep 21, 2026 of 0.0650 SGD, about +415% upside (undervalued).
What is the fair value of FRQ?
Our model-based fair value for SINGAPORE PAINCARE HOLDINGS LIMITED is 0.3348 SGD (as of Sep 29, 2026), built from audited fundamentals. Last price (from Sep 21, 2026): 0.0650 SGD.
What is the quality score of FRQ?
SINGAPORE PAINCARE HOLDINGS LIMITED has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
Our model-based price target is the fair value of 0.3348 SGD (as of Sep 29, 2026) from 13 valuation models. Cautious scenario 0.1983 SGD, optimistic scenario 0.4063 SGD. It is a calculation from audited fundamentals, not an analyst target.
What is the SINGAPORE PAINCARE HOLDINGS LIMITED stock forecast for 2026?
Our models put fair value at 0.3348 SGD, about +415% upside versus the last price from Sep 21, 2026 of 0.0650 SGD (undervalued). Cautious scenario 0.1983 SGD, optimistic scenario 0.4063 SGD. The calculation is refreshed regularly with new filings.
What is the revenue of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
SINGAPORE PAINCARE HOLDINGS LIMITED reported trailing-twelve-month revenue of about 26.6M SGD (latest available figure, as of Sep 29, 2026).
Does SINGAPORE PAINCARE HOLDINGS LIMITED pay a dividend?
SINGAPORE PAINCARE HOLDINGS LIMITED currently shows a dividend yield of about 5.84% relative to its recent price (as of Sep 29, 2026).
What growth is priced into SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
For today's price to be fair in a discounted-cash-flow model, SINGAPORE PAINCARE HOLDINGS LIMITED would have to grow free cash flow by -9.5 % per year for five years (discount rate 8.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +47.2 % per year. As of Sep 29, 2026.
What discount rate (WACC) does the fair value of FRQ use?
Our models discount SINGAPORE PAINCARE HOLDINGS LIMITED at 8.3 %: a base by market capitalisation (nano), damped by beta 0.05, country premium for Singapore. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For SINGAPORE PAINCARE HOLDINGS LIMITED that is -9.5 % per year a year over ten years, using the same discount rate (8.3 %) and the same formula as our fair value.
How much growth has SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ) delivered so far?
Over the past 5 years revenue at SINGAPORE PAINCARE HOLDINGS LIMITED grew +47.2 % a year. The price currently implies -9.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ) growing?
The median revenue growth in the sector is +5.1 % a year. That is the yardstick for the growth priced into SINGAPORE PAINCARE HOLDINGS LIMITED (-9.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
The free-cash-flow yield on the price is 8.68 %: that much free cash flow SINGAPORE PAINCARE HOLDINGS LIMITED produces per unit of market value. When it exceeds the discount rate of our models (8.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For SINGAPORE PAINCARE HOLDINGS LIMITED it is 0.3348 SGD per share (as of Sep 29, 2026), against a price of 0.0650 SGD. It is the blended result of 13 valuation models (cash flow, earnings, asset, dividend).
Is SINGAPORE PAINCARE HOLDINGS LIMITED stock overvalued or undervalued in 2026?
As of Sep 29, 2026, FRQ trades below its calculated fair value: price 0.0650 SGD, fair value 0.3348 SGD, a gap of about +415% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FRQ?
No. The price is what the market pays today (0.0650 SGD); the fair value is what the company's own numbers justify (0.3348 SGD). For SINGAPORE PAINCARE HOLDINGS LIMITED the two are 0.2698 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is SINGAPORE PAINCARE HOLDINGS LIMITED worth?
The market values SINGAPORE PAINCARE HOLDINGS LIMITED at about 11.1M SGD (market capitalisation, as of Sep 29, 2026). Per share that is 0.0650 SGD; our models calculate a fair value of 0.3348 SGD per share.
What do the bullish and bearish scenarios say about FRQ?
Our models span a range for SINGAPORE PAINCARE HOLDINGS LIMITED: cautious scenario 0.1983 SGD, base 0.3348 SGD, optimistic 0.4063 SGD per share (as of Sep 29, 2026, price 0.0650 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
Balance-sheet figures for SINGAPORE PAINCARE HOLDINGS LIMITED (as of Sep 29, 2026): return on equity −21.8%, debt of 0.03 per unit of equity. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is FRQ from its 52-week high?
SINGAPORE PAINCARE HOLDINGS LIMITED trades at 0.0650 SGD, about 59% below its 52-week high of 0.1600 SGD and 8% above the low of 0.0600 SGD (as of Sep 21, 2026). Distance from the high says nothing about value: that is what the fair value of 0.3348 SGD is for.
Which stocks are comparable to SINGAPORE PAINCARE HOLDINGS LIMITED?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is SINGAPORE PAINCARE HOLDINGS LIMITED stock attractive at the current price?
The data as of Sep 29, 2026: price 0.0650 SGD, calculated fair value 0.3348 SGD (+415%), Quality Score 59/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FRQ calculated?
We run SINGAPORE PAINCARE HOLDINGS LIMITED through 13 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.3348 SGD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. SINGAPORE PAINCARE HOLDINGS LIMITED currently trades 81 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
The latest price we hold is from Sep 21, 2026 and stands at 0.0650 SGD. Our model-based fair value is 0.3348 SGD, about +415% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with SINGAPORE PAINCARE HOLDINGS LIMITED right now?
The price is below even our cautious bear case (0.1983 SGD). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (59/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (0.1983 SGD to 0.4063 SGD) leaves room in how you read the outcome.
Key figures of SINGAPORE PAINCARE HOLDINGS LIMITED
How large is the market capitalisation of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
The market capitalisation of SINGAPORE PAINCARE HOLDINGS LIMITED is 11.1M SGD (≈ $8.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
The price-to-sales ratio of SINGAPORE PAINCARE HOLDINGS LIMITED is 0.39 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
Earnings per share at SINGAPORE PAINCARE HOLDINGS LIMITED are −0.0300 SGD. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
The dividend yield of SINGAPORE PAINCARE HOLDINGS LIMITED is 5.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
The net margin of SINGAPORE PAINCARE HOLDINGS LIMITED is −18.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
The return on equity (ROE) of SINGAPORE PAINCARE HOLDINGS LIMITED is −21.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
On an EBIT basis the return on assets of SINGAPORE PAINCARE HOLDINGS LIMITED is 16.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
The operating margin of SINGAPORE PAINCARE HOLDINGS LIMITED is 1.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
Revenue at SINGAPORE PAINCARE HOLDINGS LIMITED is growing −2.9% versus a year earlier (3y avg +34.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at SINGAPORE PAINCARE HOLDINGS LIMITED (FRQ)?
Earnings per share at SINGAPORE PAINCARE HOLDINGS LIMITED are growing −54.1% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch SINGAPORE PAINCARE HOLDINGS LIMITED in the live analysis
One click puts SINGAPORE PAINCARE HOLDINGS LIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
